Skip to main content

Table 1 Clinical characteristics of 135 HIV-infected patients who were admitted to the ICUs at the National Taiwan University Hospital from 2001 to 2010

From: Admissions to intensive care unit of HIV-infected patients in the era of highly active antiretroviral therapy: etiology and prognostic factors

Characteristics 135 patients
Median age (years) 39 (31-50)
Male sex 123 (91.1)
Race/ethnicity  
   Taiwanese 133 (98.5)
   other Asians 2 (1.5)
HIV risk factor  
   Homosexual 53 (39.3)
   Bisexual 7 (5.2)
   Injecting drug use 16 (11.9)
   Transfusion-related 3 (2.2)
   Heterosexual/other/unknown 56 (41.5)
HIV-related characteristics  
   Newly diagnosed HIV infection 60 (44.4)
   Time since HIV diagnosis (month) 1.23 (0-36)
   Time since AIDS diagnosis (month) 0.73 (0-26)
   Prior HAART at hospital admission 49 (36.3)
   Duration of HAART for patients on prior HAART (month)a 13 (6-48)
   HAART initiated during ICU stay 12 (8.9)
   HAART use in ICU 82 (60.7)
   HIV viral load (copies/ml)b 217,000 (34,500-631,500)
   CD4 lymphocyte count (cells/mm3)c 30 (13-103)
Organ failure status  
   Mechanical ventilator use 106 (78.5)
   Shock (use of vasopressors > 24 hours) 49 (36.3)
   Renal replacement therapy 11 (8.1)
Time from hospitalization to ICU admission (days) 2 (0-9.0)
Laboratory data  
   Albumin (g/dL)d 2.83 (2.40-3.40)
   LDH (units/L)e 966.5 (686.5-1446.25)
APACHE II score 19 (15-25)
in-ICU mortality 50 (37.0)
in-hospital mortality 66 (48.9)
  1. Values are given as median (interquartile) or number (%), unless otherwise indicated.
  2. aData were available for 49 patients with prior HAART at hospital admission.
  3. bData were available for 121 patients.
  4. cData were available for 129 patients.
  5. dData were available for 127 patients.
  6. eData were available for 114 patients.
  7. APACHE II, Acute Physiology and Chronic Health Evaluation II; HAART, highly active antiretroviral therapy; LDH, lactate dehydrogenase.